VELOXIS PHARMACEUTICALS A/S: Financial statements 2024
CVR: 26527767
Source: annual report 2024, Danish Business Authority
01/04/2023 – 31/03/2024
VELOXIS PHARMACEUTICALS A/S (CVR 26527767) has filed annual accounts for 2024. Equity in the 2024 report amounted to USD -10,491,000. The company had 1 employee in the financial year.
- Equity
- USD -10,491,000
- Total Assets
- USD 3,326,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | - | - | -10.5M USD | 1 |
| 2023 | - | - | - | 2.8M USD | 1 |
| 2022 | 0 USD | 0 USD | 2.1M USD | 2.9M USD | - |
| 2021 | 45.3M USD | 45.3M USD | 1.1B USD | 1.3B USD | - |
| 2018 | 39.5M USD | 31.6M USD | -5.3M USD | 4.6M USD | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of October 9, 2024, Daisuke Matsuo is registered as adm. dir. of VELOXIS PHARMACEUTICALS A/S.
As of October 8, 2024, Mark Earl Hensley has stepped down as adm. dir. of VELOXIS PHARMACEUTICALS A/S.
About VELOXIS PHARMACEUTICALS A/S
VELOXIS PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Nordhavn, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LIFECYCLE PHARMA A/S and PHAROTECH A/S. The management consists of Daisuke Matsuo. The board consists of Keigo Nakatsukasa (chair), Daisuke Matsuo and Kenro Yuzaki. The company is owned by Asahi Kasei Corporation. The company has 1 employee (2022). In 2026, the company reported a net result of DKK -1,553,000. Equity in the 2026 report amounted to DKK 611,587,000.
